surmount-1 week 12 weight loss tirzepatide weight-loss study shows promising results Tirzepatide and blood pressure reduction:

Long-Term Weight Management: It's important to note that medication is just one tool

Weight regain can occur if lifestyle modifications are discontinued, making sustained dietary and exercise habits essential for maintaining long-term results

According to NICE guidance (NG28) , GLP-1 receptor agonists like Rybelsus may be considered when triple therapy is not effective, tolerated or contraindicated, particularly for patients with a BMI 35 kg/m (or lower in certain ethnic groups) or those with significant weight or cardiovascular concerns

While one focuses on providing the structural integrity your body needs to stay "held together," the other acts as a vigilant guardian, protecting those very structures from the wear and tear of daily life